Drugmaker Eli Lilly caps price of insulin at $35 per month

Published




Drugmaker Eli Lilly said Wednesday it would lower the prices of its most frequently used insulins by 70% and expand a program to cap out-of-pocket costs for patients at $35.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.